Skip to main content
Transcenta Holding Limited logo

Transcenta Holding Limited — Investor Relations & Filings

Ticker · 6628 ISIN · KYG9005B1041 HKEX Manufacturing
Open in API
Filings indexed 482 across all filing types
Latest filing 2023-02-16 Regulatory Filings
Country HK Hong Kong
Listing HKEX 6628

About Transcenta Holding Limited

http://www.transcenta.com

Transcenta Holding Limited is a clinical-stage global biotherapeutics company specializing in the discovery, research, development, and manufacturing of differentiated antibody-based therapeutics. The company operates a fully integrated platform, utilizing a unique antibody generation platform based on Immune Tolerance Breaking Technology to generate candidate leads. Its robust pipeline includes therapeutic antibody molecules targeting oncology and selected non-oncology indications, such as bone and kidney disorders. The company employs advanced bioprocessing technologies, including perfusion-based continuous bioprocessing, to accelerate process development and reduce manufacturing costs.

Recent filings

Filing Released Lang Actions
NOTICE OF EXTRAORDINARY GENERAL MEETING
Regulatory Filings Classification · 95% confidence The document is a notice of an Extraordinary General Meeting (EGM) for Transcenta Holding Limited. It includes details about the meeting date, location, and the resolutions to be voted on, specifically related to grants of restricted share units, options, and award shares to directors and executives. The document is a formal meeting notice rather than the actual meeting minutes, voting results, or any financial report. It does not contain financial statements or detailed financial analysis. The content focuses on informing shareholders about the meeting and the agenda items to be considered. Therefore, this document fits the category of a shareholder meeting notice, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since it is a notice of the meeting itself and not the solicitation materials or proxy statement, it is best classified under Regulatory Filings (RNS) as a general regulatory announcement related to shareholder meetings that does not fit other specific categories. The document length (7958 characters) and content confirm it is not a brief announcement but a formal notice. Hence, the most appropriate classification is Regulatory Filings (RNS).
2023-02-16 English
(1) GRANT OF RESTRICTED SHARE UNITS (2) GRANT OF AWARD SHARES AND OPTIONS AND (3) NOTICE OF EXTRAORDINARY GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from Transcenta Holding Limited regarding the grant of restricted share units (RSUs), award shares, and options, and it includes a notice of an Extraordinary General Meeting (EGM). It contains detailed information about equity incentive plans, grant announcements, and proxy arrangements for the EGM. The content is focused on shareholder voting matters related to equity grants and meeting notices rather than financial results, audit opinions, or regulatory certifications. The presence of a formal meeting notice and proxy form indicates this is a solicitation and information document for shareholders to vote on specific corporate actions. Therefore, this document fits the category of Proxy Solicitation & Information Statement (PSI).
2023-02-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return report for movements in securities of Transcenta Holding Limited, including authorized share capital, issued shares, share options, and other share-related movements. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules, specifically Chapter 19B. The document includes confirmations by an executive director regarding the authorization and compliance of securities issued during the month. The content focuses on share capital changes, share options, and repurchases, without any financial performance data, earnings, or management discussion. It is not an annual or interim report, earnings release, or investor presentation. It is a regulatory filing reporting share capital movements and confirmations related to securities issuance, fitting the category of Regulatory Filings (RNS). The document length is over 12,000 characters, so it is not a mere announcement of a report but a substantive regulatory filing.
2023-02-06 English
Next Day Disclosure Returns
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Transcenta Holding Limited. It includes detailed information on share repurchases and share issues under a share award scheme, with dates and quantities of shares involved. The document references compliance with listing rules of the Stock Exchange of Hong Kong and confirms authorization by the board of directors. This type of filing is a regulatory disclosure about share capital changes, specifically share issues and repurchases, which fits the category of Share Issue/Capital Change announcements. The document is not a full financial report, earnings release, or management discussion, but a formal notification of capital changes. Therefore, the appropriate classification is Share Issue/Capital Change (SHA). The document length and detail support a high confidence level.
2023-02-02 English
CLARIFICATIONS REGARDING THE GRANT OF RESTRICTED SHARE UNITS IN DECEMBER 2022 AND GRANT OF AWARD SHARES AND OPTIONS
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Transcenta Holding Limited regarding the grant of restricted share units (RSUs), award shares, and options under equity incentive plans. It discusses details of share grants to directors and executives, compliance with listing rules, and conditions for shareholder approval. The content focuses on equity incentive schemes, share grants, and related regulatory compliance disclosures. There is no financial performance data, earnings information, or management discussion of results. The document is not a full report but an announcement about share-based compensation and related approvals. This fits the category of Share Issue/Capital Change (SHA), as it involves announcements about share grants and options under share schemes affecting capital structure.
2023-01-26 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Share Issue/Capital Change Classification · 95% confidence The document is a detailed monthly return report for movements in securities of Transcenta Holding Limited, including authorized share capital, issued shares, share options, repurchases, and cancellations. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The content focuses on share capital changes, share options, and confirmations related to securities issuance and repurchase. There is no indication of financial performance data, earnings, management discussion, or audit information. The document is regulatory in nature, reporting share capital movements and confirmations to the stock exchange, which aligns with a Major Shareholding Notification or Share Issue/Capital Change. Given the detailed share capital movements and repurchase information, the best fit is Share Issue/Capital Change (SHA). The document length and detail confirm it is not a brief announcement but a substantive regulatory filing on capital changes.
2023-01-09 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.